New treatments for macular degeneration
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Drug discovery
RNA epigenetics is coming of age
Interviewee/Contributor
Oliver Rausch
Organisation
Storm Therapeutics Ltd
Ion channel drug discovery and modern medicine
Interviewee/Contributor
Marc Rogers
Organisation
Metrion Biosciences Ltd
Forendo Pharma's new approach to endometriosis
Interviewee/Contributor
Maarit Merla
Organisation
Forendo Pharma Ltd
Galapagos shows that the fittest can survive
Interviewee/Contributor
Piet Wigerinck and Walid Abi-Saab
Organisation
Galapagos NV
Exploring new business models for antibiotics
Interviewee/Contributor
Heather Graz
Organisation
Neem Biotech Ltd
Vivoryon Therapeutics tests Alzheimer's drug
Interviewee/Contributor
Ulrich Dauer
Organisation
Vivoryon Therapeutics AG
Gut microbiota is new frontier in CNS research
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Taking on the Alzheimer's conundrum
Interviewee/Contributor
Reisa Sperling
Organisation
Harvard Medical School
Revisiting antibody-drug conjugates
Interviewee/Contributor
Chris Martin
Organisation
ADC Therapeutics SA